Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial

BACKGROUND: The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III trial comparing rivaroxaban versus aspirin in patients with recent ESUS. AIMS: We aimed to describe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Stroke Cerebrovasc Dis
Main Authors: Kasner, Scott E., Lavados, Pablo, Sharma, Mukul, Wang, Yongjun, Wang, Yilong, Dávalos, Antoni, Shamalov, Nikolay, Cunha, Luis, Lindgren, Arne, Mikulik, Robert, Arauz, Antonio, Lang, Wilfried, Czlonkowska, Anna, Eckstein, Jens, Gagliardi, Rubens, Amarenco, Pierre, Ameriso, Sebastián F., Tatlisumak, Turgut, Veltkamp, Roland, Hankey, Graeme J., Toni, Danilo S., Bereczki, Daniel, Uchiyama, Shinichiro, Ntaios, George, Yoon, Byung-Woo, Brouns, Raf, DeVries Basson, M.M., Endres, Matthias, Muir, Keith, Bornstein, Natan, Ozturk, Serefnur, O’Donnell, Martin, Mundl, Hardi, Pater, Calin, Weitz, Jeffrey, Peacock, W. Frank, Swaminathan, Balakumar, Kirsch, Bodo, Berkowitz, Scott D., Peters, Gary, Pare, Guillaume, Themeles, Ellison, Shoamanesh, Ashkan, Connolly, Stuart J., Hart, Robert G.
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701183/
https://ncbi.nlm.nih.gov/pubmed/29525076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.027
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker